Application 065439

Type
ANDA
Sponsor
FRESENIUS KABI USA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001AZTREONAMAZTREONAMINJECTABLE;INJECTION500MG/VIALNoNo
002AZTREONAMAZTREONAMINJECTABLE;INJECTION1GM/VIALNoNo
003AZTREONAMAZTREONAMINJECTABLE;INJECTION2GM/VIALNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
63323-401AztreonamAZTREONAMFresenius Kabi USA, LLCANDACurrent
63323-401AztreonamAZTREONAMFresenius Kabi USA, LLCANDACurrent
63323-401AztreonamAZTREONAMFresenius Kabi USA, LLCANDACurrent
63323-401AztreonamAZTREONAMFresenius Kabi USA, LLCANDACurrent
63323-401AztreonamAZTREONAMFresenius Kabi USA, LLCANDACurrent
63323-401AztreonamAZTREONAMFresenius Kabi USA, LLCANDACurrent
63323-401AztreonamAZTREONAMFresenius Kabi USA, LLCANDACurrent
63323-401AztreonamAZTREONAMFresenius Kabi USA, LLCANDACurrent
63323-401AztreonamAZTREONAMFresenius Kabi USA, LLCANDACurrent
63323-401AztreonamAZTREONAMFresenius Kabi USA, LLCANDACurrent
63323-401AztreonamAZTREONAMFresenius Kabi USA, LLCANDACurrent
63323-401AztreonamAZTREONAMFresenius Kabi USA, LLCANDACurrent
63323-402AztreonamAZTREONAMFresenius Kabi USA, LLCANDACurrent
63323-402AztreonamAZTREONAMFresenius Kabi USA, LLCANDACurrent
63323-402AztreonamAZTREONAMFresenius Kabi USA, LLCANDACurrent
63323-402AztreonamAZTREONAMFresenius Kabi USA, LLCANDACurrent
63323-402AztreonamAZTREONAMFresenius Kabi USA, LLCANDACurrent
63323-402AztreonamAZTREONAMFresenius Kabi USA, LLCANDACurrent
63323-402AztreonamAZTREONAMFresenius Kabi USA, LLCANDACurrent
63323-402AztreonamAZTREONAMFresenius Kabi USA, LLCANDACurrent
63323-402AztreonamAZTREONAMFresenius Kabi USA, LLCANDACurrent
63323-402AztreonamAZTREONAMFresenius Kabi USA, LLCANDACurrent
63323-402AztreonamAZTREONAMFresenius Kabi USA, LLCANDACurrent
63323-402AztreonamAZTREONAMFresenius Kabi USA, LLCANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
42817ORIG2016-07-28